BAX
Baxter International Inc.
NYSE · Healthcare · Medical - Instruments & Supplies · US
$25.83
+1.02%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+34.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 3, 2026 | Foster Julie · officer: President, Front Line Care | F-InKind | 2,098 | $26 |
| Sep 3, 2026 | Hider Andrew P. · director, officer: President and CEO | F-InKind | 54,276 | $26 |
| Sep 3, 2026 | Teaff James · officer: President, CCS | F-InKind | 750 | $25 |
| May 7, 2026 | MORRISON PATRICIA · director | A-Award | 12,836 | $0.00 |
| May 7, 2026 | SCHLICHTING NANCY M · director | A-Award | 12,836 | $0.00 |
| May 7, 2026 | Ampofo William A. II · director | A-Award | 12,836 | $0.00 |
| May 7, 2026 | Shafer David Brent · director, other: Chair of the Board | A-Award | 12,836 | $0.00 |
| May 7, 2026 | Wilkes David S. · director | A-Award | 12,836 | $0.00 |
| May 7, 2026 | Craig Jeffrey A · director | A-Award | 12,836 | $0.00 |
| May 7, 2026 | McDonnell Michael R. · director | A-Award | 12,836 | $0.00 |
| May 7, 2026 | Wendell Amy McBride · director | A-Award | 12,836 | $0.00 |
| Mar 10, 2026 | Rasul Reazur · officer: EVP,Group Pres,Healthcare | F-InKind | 12,674 | $18 |
| Mar 10, 2026 | Soriano Maria Cecilia · officer: Group Pres., ITT & Pharma. | F-InKind | 2,848 | $18 |
| Mar 10, 2026 | Zielinski Anita A · officer: SVP, CAO and Controller | F-InKind | 1,932 | $18 |
| Mar 10, 2026 | Rosenbloom David S. · officer: EVP and General Counsel | F-InKind | 6,620 | $18 |
| Mar 10, 2026 | Grade Joel T. · officer: EVP and CFO | F-InKind | 8,153 | $18 |
| Mar 3, 2026 | Soriano Maria Cecilia · officer: Group Pres., ITT & Pharma. | A-Award | 57,471 | $20 |
| Mar 3, 2026 | Rosenbloom David S. · officer: EVP and General Counsel | A-Award | 64,655 | $20 |
| Mar 3, 2026 | Zielinski Anita A · officer: SVP, CAO and Controller | A-Award | 30,864 | $0.00 |
| Mar 3, 2026 | Grade Joel T. · officer: EVP and CFO | A-Award | 103,448 | $20 |
| Mar 3, 2026 | Carlisle Cynthia · officer: Executive Vice President, CHRO | A-Award | 11,871 | $0.00 |
| Mar 3, 2026 | Carlisle Cynthia · officer: Executive Vice President, CHRO | A-Award | 43,103 | $20 |
| Mar 3, 2026 | Rasul Reazur · officer: EVP,Group Pres,Healthcare | F-InKind | 1,614 | $20 |
| Mar 3, 2026 | Grade Joel T. · officer: EVP and CFO | A-Award | 42,735 | $0.00 |
| Mar 3, 2026 | Soriano Maria Cecilia · officer: Group Pres., ITT & Pharma. | F-InKind | 1,852 | $20 |
| Mar 3, 2026 | Rosenbloom David S. · officer: EVP and General Counsel | F-InKind | 1,336 | $20 |
| Mar 3, 2026 | Hider Andrew P. · director, officer: President and CEO | A-Award | 201,804 | $0.00 |
| Mar 3, 2026 | Carlisle Cynthia · officer: Executive Vice President, CHRO | A-Award | 17,806 | $0.00 |
| Mar 3, 2026 | Soriano Maria Cecilia · officer: Group Pres., ITT & Pharma. | A-Award | 23,742 | $0.00 |
| Mar 3, 2026 | Hider Andrew P. · director, officer: President and CEO | A-Award | 488,506 | $20 |
Institutional positioning
13F filings over the trailing two quarters
New 193Increased 444Reduced 463Sold out 84
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 81,842,105 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 79,400,664 | May 13, 2026 |
| PZENA INVESTMENT MANAGEMENT LLC | Increased | 65,295,393 | Aug 7, 2026 |
| PZENA INVESTMENT MANAGEMENT LLC | Reduced | 64,527,823 | Apr 24, 2026 |
| DODGE & COX | Increased | 58,386,345 | Aug 13, 2026 |
| DODGE & COX | Increased | 57,254,570 | May 14, 2026 |
| FMR LLC | Increased | 53,913,831 | Aug 13, 2026 |
| FMR LLC | Increased | 46,264,804 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 33,754,280 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 33,506,975 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 24,057,190 | Aug 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 23,993,355 | May 8, 2026 |
| STATE STREET CORP | Increased | 20,600,468 | Aug 7, 2026 |
| STATE STREET CORP | Reduced | 19,979,957 | May 15, 2026 |
| GREENHAVEN ASSOCIATES INC | Increased | 14,307,688 | Apr 6, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 3, 2026